A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
GlaxoSmithKline
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Milton S. Hershey Medical Center
M.D. Anderson Cancer Center
Medical College of Wisconsin
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
University of Virginia
Memorial Sloan Kettering Cancer Center
Bayer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Y-mAbs Therapeutics
City of Hope Medical Center
Bristol-Myers Squibb
Children's Oncology Group
Barbara Ann Karmanos Cancer Institute
Novartis
Children's Oncology Group
Celgene
Memorial Sloan Kettering Cancer Center
National Institutes of Health Clinical Center (CC)
Merck Sharp & Dohme LLC
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
University of South Florida
National Cancer Institute (NCI)
Dana-Farber Cancer Institute
Eli Lilly and Company